778-Som-Lalit Institute Of Business Management - Gujarat ...
778-Som-Lalit Institute Of Business Management - Gujarat ... 778-Som-Lalit Institute Of Business Management - Gujarat ...
• The strength in chemistry skill helps Indian companies to build up methods processes, which are more cost efficient. Weaknesses: 1) Low Indian share in world pharmaceutical market: • Indian pharmaceutical market is one of the least penetrated in the world. • However, growth has been slow to come by. • Due to this, Indian pharmaceutical giants are depending on exports for expansion. • To put things in a nutshell, India has almost 16 % of the world population while the total size of industry is just 2 per cent of the global pharmaceutical industry • India‘s share in world pharmaceutical market is very low, around 2% • There is dominance of countries like US, UK in international market. 2) Manufacturing of duplicate drugs: • Production of duplicate drugs can also pose a problem 3) Tough competition from US and UK: • We will have to face a tough competition from US, UK etc from where Qatar imports most of its pharmaceutical requirements. 4) Lack of resources: • India lacks in resources to contend with MNCs for novel Drug Discovery Research and to commercialize molecules on a global basis 5) Production of low cost drugs: • Production of spurious and low cost drugs tarnishes the image of the industry at home and abroad 6) Low investment in R & D: 16 | P a g e
• There is low investment in innovative R & D among Indian companies as compared to foreign companies 7) Bad brand image: • Bad brand image of Indian Pharmaceutical merchandise in the USA, United Kingdom & other western countries which is obstructing exports. 8) Low level of Biotechnology: • Indian companies face hindrance in terms of very low level of Biotechnology in India and also for New Drug Discovery Systems 9) Lack of experience: • India lacks experience in International Trade in this sector 10) Lack of product patent: • Indian pharmaceutical sector has been blemished by be short of of product patent • This prevents global pharmaceutical companies to initiate new drugs in the country and discourages novelty and drug discovery. • But this has provided an upper hand to the Indian pharmaceutical companies. Opportunities: 1) The Government of Qatar will continue to maintain high levels of capital spending: • The Government of Qatar will carry on upholding high levels of capital expenditure on education and health. • The government plans to invest $9.9 billion in these sectors in the 2012/2013 fiscal year, accounting for 15% of its 2010/2011 fiscal budget. 17 | P a g e
- Page 1 and 2: A GLOBAL COUNTRY REPORT ON QATAR Su
- Page 3 and 4: ACKNOWLEDGEMENT We take this opport
- Page 5 and 6: Qatar pharmaceutical industry :Qata
- Page 7 and 8: stand for around two-thirds of the
- Page 9 and 10: these factors are playing in our ad
- Page 11 and 12: Pharmaceutical industry today The I
- Page 13 and 14: According to recent reports in The
- Page 15: • They also signed Arab concord p
- Page 19 and 20: • The increase of innovative cons
- Page 21 and 22: Threats: 1) Threat from low cost co
- Page 23 and 24: As long as the municipality‘s sup
- Page 25 and 26: Feasibility Study on the alternativ
- Page 27 and 28: The Museum of Islamic Arts, which c
- Page 29 and 30: famous as the Dawlat Qaṭar, is an
- Page 31 and 32: executes needs for new business opp
- Page 33 and 34: Energy Profile Qatar Before the eme
- Page 35 and 36: investment from Qatar in crude stor
- Page 37 and 38: • Ministry of Power and Central E
- Page 39 and 40: According to Crisil report (June 20
- Page 41 and 42: Developments in Transmission Power
- Page 43 and 44: companies. Several companies have a
- Page 45 and 46: for IPPs (which are feasible for co
- Page 47 and 48: EMERGENCY SERVICES The ambulance se
- Page 49 and 50: MEDICAL R&D IN QATAR Currently, the
- Page 51 and 52: Legal The main government hospitals
- Page 53 and 54: MEDICAL TRAVEL Medical tourism, tre
- Page 55 and 56: CHCs are run by community based org
- Page 57 and 58: 5) Restaurant business in Qatar Cur
- Page 59 and 60: Doing Business in Qatar In keeping
- Page 61 and 62: Taxation Registered Entities The Ta
- Page 63 and 64: As with all Arab peoples, the ritua
- Page 65 and 66: ‗Al Jalsa‘ It‘s love that we
• The strength in chemistry skill helps Indian companies to build up methods<br />
processes, which are more cost efficient.<br />
Weaknesses:<br />
1) Low Indian share in world pharmaceutical market:<br />
• Indian pharmaceutical market is one of the least penetrated in the world.<br />
• However, growth has been slow to come by.<br />
• Due to this, Indian pharmaceutical giants are depending on exports for<br />
expansion.<br />
• To put things in a nutshell, India has almost 16 % of the world population<br />
while the total size of industry is just 2 per cent of the global pharmaceutical<br />
industry<br />
• India‘s share in world pharmaceutical market is very low, around 2%<br />
• There is dominance of countries like US, UK in international market.<br />
2) Manufacturing of duplicate drugs:<br />
• Production of duplicate drugs can also pose a problem<br />
3) Tough competition from US and UK:<br />
• We will have to face a tough competition from US, UK etc from where Qatar<br />
imports most of its pharmaceutical requirements.<br />
4) Lack of resources:<br />
• India lacks in resources to contend with MNCs for novel Drug Discovery<br />
Research and to commercialize molecules on a global basis<br />
5) Production of low cost drugs:<br />
• Production of spurious and low cost drugs tarnishes the image of the industry<br />
at home and abroad<br />
6) Low investment in R & D:<br />
16 | P a g e
Change language